Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Roberts

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Nature Medicine|September 1, 1997
Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptidesT Hartmann, S C Bieger, B Brühl, et al.
The Journal of Comparative Neurology|October 22, 1989
Novel peptide pancreastatin: its occurrence and codistribution with chromogranin A in the central nervous system of the pigS Kar, D Bretherton-Watt, S J Gibson, et al.
Archives of General Psychiatry|December 1, 1989
Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the diseaseT J Crow, J Ball, S R Bloom, et al.
Neuroscience Letters|November 23, 1992
Prion protein immunocytochemistry helps to establish the true incidence of prion diseasesP L Lantos, I S McGill, I Janota, et al.
Annals of the New York Academy of Sciences|January 17, 1996
ApoE2 allele, Down's syndrome, and dementiaM C Royston, D Mann, S Pickering-Brown, et al.
Brain Research|December 12, 1983
Peptides, the limbic lobe and schizophreniaG W Roberts, I N Ferrier, Y Lee, et al.
Journal of Neuroscience Research|October 23, 1997
Alzheimer's disease-associated presenilin 1 in neuronal cells: evidence for localization to the endoplasmic reticulum-Golgi intermediate compartmentJ G Culvenor, F Maher, G Evin, et al.
Life Sciences|August 1, 1983
Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophreniaI N Ferrier, G W Roberts, T J Crow, et al.
Journal of the Neurological Sciences|December 1, 1983
Neuropeptides in Alzheimer type dementiaI N Ferrier, A J Cross, J A Johnson, et al.
Neurobiology of Aging|January 8, 1999
Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesisW S Griffin, J G Sheng, J E McKenzie, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Nature Medicine|September 1, 1997
Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptidesT Hartmann, S C Bieger, B Brühl, et al.
The Journal of Comparative Neurology|October 22, 1989
Novel peptide pancreastatin: its occurrence and codistribution with chromogranin A in the central nervous system of the pigS Kar, D Bretherton-Watt, S J Gibson, et al.
Archives of General Psychiatry|December 1, 1989
Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the diseaseT J Crow, J Ball, S R Bloom, et al.
Neuroscience Letters|November 23, 1992
Prion protein immunocytochemistry helps to establish the true incidence of prion diseasesP L Lantos, I S McGill, I Janota, et al.
Annals of the New York Academy of Sciences|January 17, 1996
ApoE2 allele, Down's syndrome, and dementiaM C Royston, D Mann, S Pickering-Brown, et al.
Brain Research|December 12, 1983
Peptides, the limbic lobe and schizophreniaG W Roberts, I N Ferrier, Y Lee, et al.
Journal of Neuroscience Research|October 23, 1997
Alzheimer's disease-associated presenilin 1 in neuronal cells: evidence for localization to the endoplasmic reticulum-Golgi intermediate compartmentJ G Culvenor, F Maher, G Evin, et al.
Life Sciences|August 1, 1983
Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophreniaI N Ferrier, G W Roberts, T J Crow, et al.
Journal of the Neurological Sciences|December 1, 1983
Neuropeptides in Alzheimer type dementiaI N Ferrier, A J Cross, J A Johnson, et al.
Neurobiology of Aging|January 8, 1999
Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesisW S Griffin, J G Sheng, J E McKenzie, et al.
Pageof 14